(Q50249462)

28 February 2018

title

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. (English)

1 reference

28 February 2018

0 references

7

Walter Artibani

1 reference

28 February 2018

author name string

Vincenzo Ficarra

1

1 reference

28 February 2018

Stefano Zecchini Antoniolli

2

1 reference

28 February 2018

Giacomo Novara

3

1 reference

28 February 2018

Alice Parisi

4

1 reference

28 February 2018

Simonetta Fracalanza

5

1 reference

28 February 2018

Guido Martignoni

6

1 reference

28 February 2018

publication date

1 December 2006

1 reference

28 February 2018

published in

BJU International

1 reference

28 February 2018

volume

98

1 reference

28 February 2018

issue

6

1 reference

28 February 2018

page(s)

1193-1198

1 reference

28 February 2018

Technology insight: High-intensity focused ultrasound for urologic cancers

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Pain assessment after original transperineal prostate biopsy using a coaxial needle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06561.X

10.1111/J.1464-410X.2006.06561.X

21 January 2018

Identifiers

DOI

1 reference

28 February 2018

PubMed ID

17125477

1 reference

28 February 2018